BEUDAMED
    FDA Adverse Event Injury Summary report: N

    HEARTWARE VENTRICULAR ASSIST SYSTEM - PUMP/DRIVELINE

    MDR report key: 14632249 · Received June 8, 2022

    Report

    Report Number
    3007042319-2022-05354
    Event Type
    Injury
    Date Received
    June 8, 2022
    Date of Event
    January 10, 2022
    Report Date
    August 2, 2022
    Manufacturer
    HEARTWARE, INC.
    Product Code
    DSQ
    PMA / PMN Number
    P100047
    Adverse Event
    Yes
    Report Source
    Manufacturer report
    Reporter Location
    GM
    Reporter Occupation
    PHYSICIAN
    Health Professional
    Yes

    Narratives

    Additional Manufacturer Narrative · 0

    THIS INFORMATION IS BASED ENTIRELY ON JOURNAL LITERATURE. MEDTRONIC WAS MADE AWARE OF THIS EVENT THROUGH A SEARCH OF LITERATURE PUBLICATIONS. THIS EVENT OCCURRED OUTSIDE THE US. PATIENT INFORMATION IS LIMITED DUE TO CONFIDENTIALITY CONCERNS. OF NOTE, MULTIPLE PATIENTS AND MULTIPLE MANUFACTURERS WERE NOTED IN THE ARTICLE; HOWEVER, A ONE-TO-ONE CORRELATION COULD NOT BE MADE WITH UNIQUE PRODUCT SERIAL/LOT NUMBERS. THE BASELINE GENDER/AGE CHARACTERISTICS IS UNKNOWN. THE MODEL LISTED IN THE REPORT IS A REPRESENTATIVE OF THE MODEL FAMILY, AS THERE IS NO SPECIFIC MODEL LISTED. WITHOUT A LOT NUMBER OR DEVICE SERIAL NUMBER, THE MANUFACTURING DATE CANNOT BE DETERMINED. SINCE NO DEVICE ID WAS PROVIDED, IT IS UNKNOWN IF THIS EVENT HAS BEEN PREVIOUSLY REPORTED. A REQUEST FOR ADDITIONAL INFORMATION WILL BE MADE AND UPON RECEIPT A SUPPLEMENTAL REPORT WILL BE SUBMITTED ACCORDINGLY. REFERENCED ARTICLE: ERADICATION OF VENTRICULAR ASSIST DEVICE DRIVELINE INFECTION IN PEDIATRIC PATIENTS WITH TAUROLIDINE. JOURNAL OF CARDIOVASCULAR DEVELOPMENT AND DISEASE. 2022, 9, 18. DOI: 10.3390/JCDD9010018. INVESTIGATION OF THIS EVENT IS PENDING, AND A SUPPLEMENTAL REPORT WILL BE SENT UPON ITS COMPLETION. IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED.

    Additional Manufacturer Narrative · 0

    A SUPPLEMENTAL REPORT IS BEING SUBMITTED FOR INVESTIGATION COMPLETION. PRODUCT EVENT SUMMARY: ONE (1) PUMP WITH UNKNOWN SERIAL NUMBER WAS NOT RETURNED FOR EVALUATION. REVIEW OF THE STERILITY CERTIFICATE COULD NOT BE CONDUCTED SINCE THE SERIAL NUMBER IS UNKNOWN. BASED ON THE AVAILABLE INFORMATION, THE DEVICE MAY HAVE CAUSED OR CONTRIBUTED TO THE REPORTED EVENT. POSSIBLE CLINICAL FACTORS THAT MAY HAVE CONTRIBUTED TO THIS EVENT INCLUDE THE PATIENT¿S PRE-EXISTING HISTORY AND RELATED COMORBIDITIES, THE PROGRESSION OF THEIR UNDERLYING DISEASE, ISSUES RELATED TO THE THERAPEUTIC USE OF ANTICOAGULANT AND ANTIPLATELET MEDICATIONS AND THE PATIENT'S COMPLEX POST-OPERATIVE COURSE, INCLUDING CARE OF THE DRIVELINE EXIT SITE. THERE ARE POSSIBLE PATIENT, PHARMACOLOGICAL AND PROCEDURAL FACTORS THAT MAY HAVE CONTRIBUTED TO THIS EVENT. INVESTIGATION OF THIS EVENT IS COMPLETED, AND THE FILE WILL BE CLOSED. IF NEW INFORMATION IS RECEIVED, THE FILE WILL BE RE-OPENED, AND A SUPPLEMENTAL WILL BE SUBMITTED. MEDTRONIC IS SUBMITTING THIS REPORT TO COMPLY WITH FDA REPORTING REGULATIONS UNDER 21 CFR PARTS 4 AND 803. THIS REPORT IS BASED UPON INFORMATION OBTAINED BY MEDTRONIC, WHICH THE COMPANY MAY NOT HAVE BEEN ABLE TO FULLY INVESTIGATE OR VERIFY PRIOR TO THE DATE THE REPORT WAS REQUIRED BY THE FDA. MEDTRONIC HAS MADE REASONABLE EFFORTS TO OBTAIN MORE COMPLETE INFORMATION AND HAS PROVIDED AS MUCH RELEVANT INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE OF THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEE CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. IN PARTICULAR, THIS REPORT DOES NOT CONSTITUTE AN ADMISSION BY ANYONE THAT THE PRODUCT DESCRIBED IN THIS REPORT HAS ANY ¿DEFECTS¿ OR HAS ¿MALFUNCTIONED¿. THESE WORDS ARE INCLUDED IN THE FDA 3500A FORM AND ARE FIXED ITEMS FOR SELECTION CREATED BY THE FDA TO CATEGORIZE THE TYPE OF EVENT SOLELY FOR THE PURPOSE OF REGULATORY REPORTING. MEDTRONIC OBJECTS TO THE USE OF THESE WORDS AND OTHERS LIKE THEM BECAUSE OF THE LACK OF DEFINITION AND THE CONNOTATIONS IMPLIED BY THESE TERMS. THIS STATEMENT SHOULD BE INCLUDED WITH ANY INFORMATION OR REPORT DISCLOSED TO THE PUBLIC UNDER THE FREEDOM OF INFORMATION ACT. ANY REQUIRED FIELDS THAT ARE UNPOPULATED ARE BLANK BECAUSE THE INFORMATION IS CURRENTLY UNKNOWN OR UNAVAILABLE. A GOOD FAITH EFFORT WILL BE MADE TO OBTAIN THE APPLICABLE INFORMATION RELEVANT TO THE REPORT. IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED.

    Description of Event or Problem · 0

    A JOURNAL ARTICLE WAS REVIEWED THAT CONTAINED INFORMATION REGARDING VENTRICULAR ASSIST DEVICE (VAD) DRIVELINE INFECTION IN PEDIATRIC PATIENTS. THE ARTICLE REPORTS A PATIENT WHO EXPERIENCED A THROMBOEMBOLIC STROKE IN THE MIDDLE CEREBRAL ARTERY AND BILATERAL PNEUMONIA. THIS PATIENT AND ANOTHER PATIENT BOTH HAD DRIVELINE INFECTIONS. THE PATIENTS WERE ADMITTED AND TREATED WITH ANTIBIOTICS; ONE PATIENT HAD STAPHYLOCOCCUS AUREUS AND ESCHERICHIA COLI; THE SECOND PATIENT HAD STAPHYLOCOCCUS EPIDERMIDIS. SURGICAL REVISION WAS PLANNED. THE SKIN AROUND THE EXIT SITE AND THE FIBROUS TISSUES AROUND THE DRIVELINES WERE EXCISED. THE DRIVELINES WERE MOBILIZED FROM THE SUBCUTANEOUS TISSUES AND WASHED WITH SOLUTION. THE INFECTED, PARTIALLY NECROTIC WOUND BED WAS DEBRIDED UNTIL HEALTHY UNINFECTED TISSUES WERE SEEN. THE DRIVELINES WERE BRUSHED TO REMOVE ANY ADHERENT DEBRIS. THE ENTIRE SURGICAL FIELD FROM THE EXIT SITE OF THE DRIVELINE TO THE MEDIASTINUM WAS THOROUGHLY IRRIGATED WITH SOLUTION. THE ORIGINAL SKIN EXIT SITES WERE REUSED AND NO NEW EXIT POINT FOR THE DRIVELINES WERE FASHIONED. THE SUBCUTANEOUS SPACE WAS CLOSED WITH A SUTURE. THE SKIN EDGES WERE CLOSED WITH INTERRUPTED NON-ABSORBABLE MONOFILAMENT SUTURES. NEGATIVE PRESSURE THERAPY WAS APPLIED TO THE SURGICAL WOUNDS FOR SEVEN DAYS, WITH THE SPONGE DRESSING CHANGED EVERY THREE DAYS. ASEPTIC WOUND DRESSING WAS THEN APPLIED AND CHANGED DAILY FOR THE NEXT SEVEN DAYS. PARENTERAL ANTIBIOTIC THERAPY WAS ADMINISTERED FOR A TOTAL OF 14 DAYS IN THE FIRST CASE AND 12 DAYS IN THE SECOND CASE. THE STATUS/DISPOSITION OF THE VADS APPEAR TO BE STILL IN USE. NO FURTHER PATIENT COMPLICATIONS HAVE BEEN REPORTED AS A RESULT OF THIS EVENT.

    Devices

    Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
    2216683 HEARTWARE VENTRICULAR ASSIST SYSTEM - PUMP/DRIVELINE VENTRICULAR (ASSISST) BYPASS DSQ HEARTWARE, INC. UNK

    Patients

    Seq Age Sex Outcome Treatment
    1 Unknown Required Intervention| H